PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
2.23%
Positive growth while VET shows revenue decline. John Neff would investigate competitive advantages.
10.83%
Cost growth above 1.5x VET's 3.85%. Michael Burry would check for structural cost disadvantages.
-2.71%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-4.83%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
21.70%
G&A growth 50-75% of VET's 41.07%. Bruce Berkowitz would examine operational efficiency.
No Data
No Data available this quarter, please select a different quarter.
-233.33%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
17.32%
Similar operating expenses growth to VET's 18.00%. Walter Schloss would investigate norms.
14.56%
Total costs growth 1.25-1.5x VET's 10.39%. Martin Whitman would scrutinize control.
-2.80%
Both companies reducing interest expense. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
-58.51%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-27.13%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-72.59%
Both companies show declining income. Martin Whitman would check industry conditions.
-73.19%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-574.14%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-279.14%
Pre-tax income decline while VET shows 40.58% growth. Joel Greenblatt would examine position.
-275.23%
Pre-tax margin decline while VET shows 41.48% growth. Joel Greenblatt would examine position.
104.08%
Tax expense growth above 1.5x VET's 30.63%. Michael Burry would check for concerning trends.
-233.51%
Net income decline while VET shows 49.73% growth. Joel Greenblatt would examine position.
-230.60%
Net margin decline while VET shows 50.69% growth. Joel Greenblatt would examine position.
-236.00%
EPS decline while VET shows 47.76% growth. Joel Greenblatt would examine position.
-236.00%
Diluted EPS decline while VET shows 46.97% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.